Differential modulation of the GYKI 53784-induced inhibition of AMPA currents by various AMPA-positive modulators in cerebellar Purkinje cells

European Journal of Pharmacology

Volumn 397, Issue 1, 2000, Pages 43-47

  Kapus, Gábor ^a   Bódi, Ilona ^a   Pataki, Ágnes ^a   Gueritaud, Jean Patrick ^b   Székely, József I ^a   Tarnawa, István ^a  

^a Institute for Drug Research Budapest   (Hungary)

^b U de Neurocybernetique Cell   (France)

Author keywords

1 BCP; AMPA receptor; Aniracetam; BDP 12; Cyclothiazide; GYKI 53784; Purkinje cell

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; AMPA RECEPTOR; ANIRACETAM; CYCLOTHIAZIDE; PIPERIDINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; RAT;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BENZODIAZEPINES; BENZOTHIADIAZINES; CELLS, CULTURED; CEREBELLUM; DIOXOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EXCITATORY AMINO ACID ANTAGONISTS; MEMBRANE POTENTIALS; PIPERIDINES; PURKINJE CELLS; PYRROLIDINONES; RATS; RECEPTORS, AMPA;

EID: 0343963741     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00302-2     Document Type: Article

References (15)

1. Arai A., Kessler M., Ambros-Ingerson J., Quan A., Yigiter E., Rogers G., Lynch G. Effects of a centrally active benzoylpyrrolidine drug on AMPA receptor kinetics. Neuroscience. 75:1996;573-585.
2. Bleakman D., Lodge D. Neuropharmacology of AMPA and kainate receptors. Neuropharmacology. 37:1998;1187-1204.
3. Bleakman D., Ballyk B.A., Schoepp D.D., Palmer A.J., Bath C.P., Sharpe E.F., Woolley M.L., Bufton H.R., Kamboj R.K., Tarnawa I., Lodge D. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Neuropharmacology. 35:1996;1689-1702.
4. Chapman A.G., al Zubaidy Z., Meldrum B.S. Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice. Eur. J. Pharmacol. 231:1993;301-303.
5. Donevan S.D., Rogawski M.A. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron. 10:1993;51-59.
6. Donevan S.D., Rogawski M.A. Allosteric regulation of α-amino-3-hydroxy-5-methyl-4-izoxazole-propionate receptors by thiocianate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines. Neuroscience. 87:1998;615-629.
7. Johansen T.H., Chaudhary A., Verdoorn T.A. Interactions among GYKI 52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors. Mol. Pharmacol. 48:1995;946-955.
8. Palmer A.J., Lodge D. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655. Eur. J. Pharmacol. 244:1993;193-194.
9. Partin K.M., Mayer M.L. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655. Mol. Pharmacol. 49:1996;142-148.
10. Paternain A.V., Morales M., Lerma J. Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron. 14:1995;185-189.
11. Rammes G., Swandulla D., Collingridge G.L., Hartmann S., Parsons C.G. Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurones and area CA1 in hippocampal slices. Br. J. Pharmacol. 117:1996;1209-1221.
12. Rammes G., Swandulla D., Spielmanns P., Parsons C.G. Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: experiments with outside-out patches and EPSCs in hippocampal neurons. Neuropharmacology. 37:1998;1299-1320.
13. Tarnawa I., Vizi E.S. 2,3-benzodiazepine AMPA antagonists. Restor. Neurol. Neurosci. 13:1998;41-57.
14. Yamada K.A., Turetsky D.M. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists. Br. J. Pharmacol. 117:1996;1663-1672.
15. Zorumski C.F., Yamada K.A., Price M.T., Olney J.W. A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron. 10:1993;61-67.